Role of Gait Speed, Strength, and Balance in Predicting Adverse Outcomes of Acutely Ill Older Outpatients

Carregando...
Imagem de Miniatura
Citações na Scopus
8
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER FRANCE
Citação
JOURNAL OF NUTRITION HEALTH & AGING, v.24, n.1, p.113-118, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Aim To evaluate the ability of the Short Physical Performance Battery (SPPB) for predicting 1-year adverse outcomes of acutely ill older outpatients. Methods Prospective study with 512 acutely ill older outpatients (79.4 +/- 8.3 years, 63% female) in an acute care day hospital. The SPPB was administered at admission. Participants were classified as low (0-4 points), intermediate (5-8 points), or high (9-12 points) performance. Primary outcomes were new dependence in basic activities of daily living (ADL), hospitalization, and death at 1 year. Cox models tested whether the SPPB predicted outcomes after adjustment for sociodemographic factors, comorbidities and well-known geriatric conditions. We also estimated whether the chair-stand and balance tests improve the SPPB's ability to identify patients at high risk of adverse outcomes. Results Patients with intermediate or low SPPB performance were at higher risk of 1-year new ADL dependence (32% vs 13%: adjusted hazard ratio [aHR]=2.00; 95%CI=1.18-3.37; 58% vs 13%: aHR=3.40; 95%CI=2.00-5.85, respectively), hospitalization (43% vs 29%: aHR=1.56; 95%CI=1.04-2.33; 44% vs 29%: aHR=1.80; 95%CI=1.15-2.82), and death (18% vs 6%: aHR=2.54; 95%CI=1.17-5.53; 21% vs 6%: aHR=2.70; 95%CI=1.17-6.21). Use of all three components (versus gait speed alone) improved predictions of new ADL dependence (Harrell's C=0.73 vs 0.70;P=0.01), hospitalization (Harrell's C=0.60 vs 0.57;P=0.04), and death (Harrell's C=0.67 vs 0.62;P=0.04). Conclusions The SPPB is as a powerful tool for identifying acutely ill older outpatients at high-risk of adverse outcomes. The combination of the three components of the SPPB resulted in better predictive performance than gait speed alone.
Palavras-chave
Acute care, gait speed, geriatric day hospital, prognosis, short physical performance battery
Referências
  1. Aliberti MJR, 2016, J AM GERIATR SOC, V64, P2149, DOI 10.1111/jgs.14342
  2. Bissett M, 2013, AGE AGEING, V42, P163, DOI 10.1093/ageing/afs187
  3. Bodilsen AC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154350
  4. Cesari M, 2018, J GERONTOL A-BIOL, V73, P1653, DOI 10.1093/gerona/gly011
  5. CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8
  6. Chiarantini D, 2010, J CARD FAIL, V16, P390, DOI 10.1016/j.cardfail.2010.01.004
  7. Conroy SP, 2011, AGE AGEING, V40, P436, DOI 10.1093/ageing/afr060
  8. Corsonello A, 2012, REJUV RES, V15, P41, DOI 10.1089/rej.2011.1215
  9. Ehlenbach WJ, 2015, J AM GERIATR SOC, V63, P2061, DOI 10.1111/jgs.13663
  10. FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
  11. Graf CE, 2011, AGING CLIN EXP RES, V23, P244, DOI [10.3275/7284, 10.1007/BF03337751]
  12. Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221, DOI 10.1093/gerona/55.4.M221
  13. GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902
  14. GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85
  15. Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
  16. Hatheway OL, 2017, AGE AGEING, V46, P920, DOI 10.1093/ageing/afw257
  17. Huang WNW, 2010, J AM GERIATR SOC, V58, P844, DOI 10.1111/j.1532-5415.2010.02820.x
  18. KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016
  19. Newson RB, 2010, STATA J, V10, P339, DOI 10.1177/1536867X1001000303
  20. Ostir GV, 2012, ARCH INTERN MED, V172, P353, DOI 10.1001/archinternmed.2011.1615
  21. Pavasini R, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0763-7
  22. Stenholm S, 2014, J GERONTOL A-BIOL, V69, P894, DOI 10.1093/gerona/glt175
  23. Studenshi SA, 2012, ARCH INTERN MED, V172, P358, DOI 10.1001/archinternmed.2011.1951
  24. Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x
  25. Theou O, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0823-2
  26. Van Ancum JM, 2017, EXP GERONTOL, V92, P34, DOI 10.1016/j.exger.2017.03.006
  27. Volpato S, 2011, J GERONTOL A-BIOL, V66, P89, DOI 10.1093/gerona/glq167
  28. Volpato S, 2008, J GERONTOL A-BIOL, V63, P1393, DOI 10.1093/gerona/63.12.1393
  29. Wald HL, 2019, J AM GERIATR SOC, V67, P11, DOI 10.1111/jgs.15595
  30. YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4